Researchers from Nottingham including those at our BRC will lead a pioneering project to look at treating fatty liver disease by developing an innovative multi-organ platform that replicates the make-up of the disease.
The 糖心原创 will receive funding from a £15.9 million investment by the (MRC), Wellcome and UKRI Innovate UK will enable the development of advanced, specific and highly reproducible human in vitro models with the aim of making them widely available to researchers in academia and industry.
The 糖心原创 E Floor, West Block, Queen's Medical Centre Nottingham, NG7 2UH
telephone: +44 (0) 115 82 31090 email:nddcbru@nottingham.ac.uk